Video Library

Combination Therapy in Renal-Cell Carcinoma and Quality of Life
Combination therapy continues to evolve in the renal-cell carcinoma space. However, along with improved efficacy come the tests of adverse events and their impact on quality of life. Please join Laura Wood, RN, MSN, OCN, Virginia Seery, MSN, RN, ANP-BC, AOCNP, and Megan Price, MSN, APRN, FNP-C, as they discuss the ways in which drug combinations improve outcomes but also present their own set of challenges for patients’ quality of life.
The Impact of New Driver Mutations on Treatment of NSCLC
Identification of new actionable targets and driver mutations have revolutionized the treatment of NSCLC
Educating Patients About the Need to Wait for Biomarker Test Results
Explaining the Treatment Trajectory in NSCLC
The Multidisciplinary Care Approach to Cancer Care Management
There are an ever-growing number of treatment options that are contributing to more successful outcomes and higher survival rates for cancer patients. The number of care providers that cancer patients need during their journey is also expanding. Please join Laura Wood, RN, MSN, OCN, and Virginia Seery, MSN, RN, ANP-BC, AOCNP, as they discuss the role of the multidisciplinary care team approach to deliver the best possible treatment for cancer patients.
The Clinical Advantages of Combination Therapies in Advanced RCC
Nephrectomy is often the initial treatment for renal-cell cancer (RCC), but systemic therapy is frequently required for advanced RCC. Single-agent targeted therapies are only somewhat effective, which led to the development of immunotherapies and combination therapies (which include immunotherapies). Laura Wood, RN, MSN, OCN, and Virginia Seery, MSN, RN, ANP-BC, AOCNP, discuss the clinical advantages of combination therapies in patients with advanced RCC.
Improving the Patient Experience by Helping Patients Navigate Their Cancer Care
Laura Wood, RN, MSN, OCN, Megan Price, MSN, APRN, FNP-C, and Virginia Seery, MSN, RN, ANP-BC, AOCNP, discuss their roles and responsibilities within their academic oncology centers as valuable members of a multidisciplinary team that helps patients successfully navigate the spectrum of patient care. They also detail how they apply the principles of patient-centered care to improve outcomes for patients.
Reflecting on Advances in NSCLC Treatment Over the Past 10 Years
Counseling Patients and Their Families on Treatment Options in NSCLC
The Role of NGS Testing in NSCLC
The Affordable Care Act and the Cancer Community
The Affordable Care Act touches many areas of the cancer community and the healthcare system. Watch Joanna Fawzy Morales, Esq., CEO of Triage Cancer; and Monica Fawzy Bryant, Esq., COO of Triage Cancer, discuss the future of the Affordable Care Act.
Patient Support Services in Multiple Myeloma
Charise Gleason, MSN, NP-C, AOCNP, Kathryn Maples, PharmD, BCOP, and Chelsea Sprouse, FNP-C, discuss their personal experiences with patient support groups for multiple myeloma patients that deal with pharmacy issues, financial problems, management of pain and neuropathy, psychological and nutritional support.
Page 5 of 10
Results 49 - 60 of 117

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
    Profession or Role
    Primary Specialty or Disease State